Hikma Pharmaceuticals PLC (HIKL.XC) Stock Price, News & Chart

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close1,751.00

Open1,725.00

Day range1,645.501,749.00

52-week range1,187.001,760.00

Off day high−2.29%

Off 52-week high−2.90%

Volume219.27K

Avg. volume (3M)91.26K

Market cap3.70B

EPS (TTM)1.31

Forward P/E—

P/E ratio (TTM)13.05

Dividend yield3.68% (0.6400)

Beta (5Y)0.63

Shares outstanding216.35M

Short interest—

Earnings dateAug 6, 2026

Analyst target—

Profit margin11.32%

Related companies

Compare ›

Companies on Cboe UK of a similar market value (3.65B).

Company	Mkt cap	Price	Today
AIXTRON SEAIXAD.XC · Semiconductor Equipment & Materials	3.54B	31.03	0.00%
Renishaw plcRSWL.XC · Scientific & Technical Instruments	3.47B	4,772.00	−4.45%
Rightmove plcRMVL.XC · Internet Content & Information	4.26B	564.00	+0.14%
Burberry Group plcBRBYL.XC · Luxury Goods	4.03B	1,125.50	+0.99%
Rotork plcRORL.XC · Specialty Industrial Machinery	4.04B	493.60	+0.02%
Stadler Rail AGSRAILZ.XC · Railroads	3.23B	32.24	+0.19%
Rosebank Industries plcROSEL.XC · Asset Management	3.24B	321.50	−0.46%
Softcat plcSCTL.XC · Electronics & Computer Distribution	3.13B	1,587.00	−1.79%

What visitors to Hikma Pharmaceuticals's page also look at.

Company	Mkt cap	Price	Today
Sage Group PLC/TheSGEL.XC	11.13B	1,202.00	+0.71%
Haleon PLCHLNL.XC	30.59B	343.00	+2.05%
Compass Group PLCCPGL.XC	57.91B	33.88	−1.02%
Autotrader Group PLCAUTOL.XC	4.70B	566.40	−1.63%
JD Sports Fashion PLCJDL.XC	4.73B	96.76	−0.37%

From the 4Search instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 15 min.

Latest news

All HIKL.XC news ›

Defense World·Oct 27Positive

Hikma Pharmaceuticals PLC (LON:HIK) Stock Has Consensus Price Target of GBX 2,085.83

Shares of Hikma Pharmaceuticals PLC (LON:HIK – Get Free Report) have received an average rating of “Buy” from the six research firms that are presently covering the company, Marketbeat.com reports. Six equities research analysts have rated…

HII SKHY

Seeking Alpha·Oct 22

Hikma Pharmaceuticals PLC (HKMPY) Discusses R&D Vision and Expansion in Respiratory, Nasal, Semi-Solids and Liquid Platforms - Slideshow

2026-10-22. The following slide deck was published by Hikma Pharmaceuticals PLC in conjunction with this event. The following slide deck was published by Hikma Pharmaceuticals PLC in conjunction with this event.

SNY

Markets Daily·Oct 23Positive

Hikma Pharmaceuticals Spotlights R&D Shift, Nasal Epinephrine Filing Progress

Posted by Danessa Lincoln on Oct 23rd, 2026 Hikma Pharmaceuticals (LON:HIK) outlined a more centralized research and development strategy at the first event in its R&D Spotlight series, highlighting investments in respiratory, nasal,…

LLY JNJ MRK PFE

@kalkineuk·Oct 14Positive

Why Is Hikma Pharmaceuticals (LSE:HIK) Stock In Focus Today After Reiterating Its Outlook?

The update paints a picture of a business that is investing while still delivering profit growth. Management pointed to new product launches, a strengthened pipeline, fresh partnerships and manufacturing optimisation as the pillars of…

LLY NVO PFE JNJ

From the 4Search news index, newest first.

In the news

4mentions in 30 days

4with it in the headline

Positivesentiment

Most coverage from

defenseworld.net1
kalkinemedia.com1
seekingalpha.com1
themarketsdaily.com1

Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 4 articles, not a forecast.